
Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …

Cipher Pharmaceuticals has appointed Lynne Bulger as vice president of its medical and clinical affairs whilst also promoting Peter Weiler …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

